Anti-MMP9 抗体 [EP1254] - BSA and Azide free
Anti-MMP9 antibody [EP1254] - BSA and Azide free
- RabMAb
- Recombinant
- 詳細を見る
4
(1 Review)
|
(4 Publications)
Rabbit Recombinant Monoclonal MMP9 antibody. Carrier free. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Rat, Recombinant full length protein - Human samples. Cited in 4 publications.
別名を表示する
CLG4B, MMP9, Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
Immunocytochemistry/Immunofluorescence analysis of U-2 OS (human osteosarcoma) cells labeling MMP9 with ab76003 at 1/500 (4.3 μg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000, 2 μg/mL) was used as the secondary antibody. Cells were counterstained with ab195889 Anti-Alpha Tubulin antibody [DM1A] (1/200, 2.5 μg/mL) - Microtubule Marker (Alexa Fluor® 594). DAPI (blue) was used as a nuclear counterstain.
Confocal image showing cytoplasmic staining onU-2 OS cells, the expression increased after treatment with TPA (200 nM) for 24 hours (middle panel).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control with both TPA treated and untreated U-2 OS cells.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human gastric adenocarcinoma tissue labeling MMP9 with unpurified ab76003 at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
Overlay histogram showing permeabilized A431 (Human epidermoid carcinoma cell line) cells stained with unpurified ab76003 (pink line).
Negative control antibody (green line) was rabbit IgG.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This IHC data was generated using the same anti-MMP9 antibody clone, EP1254, in a different buffer formulation (cat# ab76003).
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human spleen tissue labelling MMP9 with purified ab76003 at 1/1000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- Functional Study
Unknown
Functional Study - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
Unpurified ab76003 staining MMP9 in U87-MG cells treated with domoic acid (ab120338), by ICC/IF. Increase of MMP9 expression correlates with increased concentration of domoic acid, as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120338 (domoic acid) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with unpurified ab76003 (1/200) dilution was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
- WB
Lab
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
Western blot : Rabbit Monoclonal[EP1254] to MMP9 76003 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 90 kDa in Wild-type A549 TPA-treated (80nM, 24h) cell lysates with no signal observed at this size in MMP9 knockout A549 TPA-treated (80nM, 24h) cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 TPA-treated (80nM, 24h) at 20 µg
Lane 2:
Wild-type A549 Vehicle Control TPA (0nM, 24h) at 20 µg
Lanes 3 - 4:
Western blot - Human MMP9 knockout A549 cell line (ab286527) at 20 µg
Lane 5:
Human Lung at 20 µg
Lane 6:
MOLT-4 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 90 kDa
false
- WB
AbReview55690****
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1/5000 dilution
Lanes 1 - 2:
HTB94 (human chondrosarcoma cell line) cell lysate at 10 µg
Lanes 3 - 4:
HTB94 (human chondrosarcoma cell line) conditioned media at 10 µg
Secondary
All lanes:
Goat anti-rabbit IgG at 1/5000 dilution
Predicted band size: 78 kDa
true
Data courtesy of an anonymous AbReview
- WB
Lab
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
Running buffer : MOPS.
Conditions : Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) and ab8245 (loading control to GAPDH; 0.1 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) and goat anti-mouse (red) at 1 : 10,000 dilution for 1 hour at room temperature.
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1.5 µg/mL
Lane 1:
Control U937 at 100 µg
Lane 2:
Stimulated U937 (24 hours with 10 ng x mL-1 PMA (<a href='/products/biochemicals/phorbol-12-myristate-13-acetate-pma-pkc-activator-ab120297'>ab120297</a>), 3 final hours with 3 ug x mL-1 of Brefeldin (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)) at 100 µg
Lane 3:
Human tonsils at 20 µg
Secondary
All lanes:
Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa
false
- WB
Supplier Data
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
Blocking and dilution buffer : 5% NFDM/TBST.
The expression of MMP-9 can be stimulated by various agents, such as inflammatory cytokine, growth factor, and 12-O-tetradecanoylphorbol-13-acetate (TPA) (PMID : 21047770, 28969043).
Based on our preliminary data, ab76003 detects no or weak band of interest in the untreated cell lines at the dilution of 1/200. Treatment increasing the expression of MMP-9 is recommended when using this antibody.
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1/200 dilution
Lane 1:
LoVo (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
A549 (Human lung carcinoma epithelial cell) serum starved overnight whole cell lysate at 20 µg
Lane 7:
A549 (Human lung carcinoma epithelial cell) serum starved overnight, then treated with 80nM TPA for 24 hours whole cell lysate at 20 µg
Lane 8:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight whole cell lysate at 20 µg
Lane 9:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) serum starved overnight, then treated with 200nM TPA for 24 hours whole cell lysate at 20 µg
Lane 10:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 84-82 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003). Blocking and diluting buffer and concentration : 5% NFDM/TBST. Exposure time : 3 seconds; 40 seconds. ab181602 was used as loading control for GAPDH. Although MMP9 has been studied in brain in some publications, ab76003 was unable to detect signal in normal brain tissue, this may because MMP9 expression level is low in normal brain and would be increased in abnormal conditions like injury (PMID : 31198417).
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1/1000 dilution
Lane 1:
Human lung tissue lysate at 20 µg
Lane 2:
Human brain tissue lysate at 20 µg
Lane 3:
Human spleen tissue lysate at 20 µg
Lane 4:
Human lymph node tissue lysate at 20 µg
Lane 5:
Rat lung tissue lysate at 20 µg
Lane 6:
Rat brain tissue lysate at 20 µg
Lane 7:
Rat spleen tissue lysate at 20 µg
Lane 8:
Rat kidney tissue lysate at 20 µg
Lane 9:
Rat lymph node tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 29 kDa
false
- WB
Lab
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1/1000 dilution
All lanes:
Rat kidney tissue lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 78 kDa
Observed band size: 84-92 kDa
false
- WB
Unknown
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
Running buffer : MOPS.
Conditions : Denatured/reduced.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with ab76003 (rabbit-anti MMP9; 1.5 ug/mL) for 48 hours at 4°C. Before imaging, antibody binding was detected using infrared-labeled goat anti-rabbit (green) at 1 : 10,000 dilutions for 1 hour at room temperature.
All lanes:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 1.5 µg/mL
All lanes:
Western blot - Recombinant Human MMP9 protein (Proenzyme) (<a href='/products/proteins-peptides/recombinant-human-mmp9-protein-proenzyme-ab82955'>ab82955</a>) at 0.1 µg
Secondary
All lanes:
Goat anti-rabbit at 1/10000 dilution
Predicted band size: 78 kDa
Observed band size: 89 kDa
false
- WB
Lab
Western blot - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab76003).
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with anti-MMP9 antibody [EP1254] (ab76003; 5 microgram per mL) overnight at 4°C. Antibody binding was detected using infrared labeled goat anti-rabbit (green) antibody (diluted 1 : 20000) for 1 hour at room temperature before imaging.
Lanes 1 - 2:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 5 µg
Lane 3:
Western blot - Anti-MMP9 antibody [EP1254] (<a href='/products/primary-antibodies/mmp9-antibody-ep1254-ab76003'>ab76003</a>) at 5 µg/mL
Lane 1:
Western blot - Native human MMP9 protein (dimer) (<a href='/products/proteins-peptides/native-human-mmp9-protein-dimer-ab168863'>ab168863</a>) at 0.1 µg
Lane 2:
Western blot - Native human MMP9 protein (Proenzyme, monomer) (<a href='/products/proteins-peptides/native-human-mmp9-protein-proenzyme-monomer-ab157344'>ab157344</a>) at 0.1 µg
Lane 3:
Western blot - Recombinant Mouse MMP9 protein (<a href='/products/proteins-peptides/recombinant-mouse-mmp9-protein-ab39309'>ab39309</a>) at 0.1 µg
Secondary
All lanes:
Infrared labeled goat anti-rabbit (green) antibody at 1/20000 dilution
Predicted band size: 78 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-MMP9 antibody [EP1254] - BSA and Azide free (AB204850)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
関連する標識済み抗体及び組成の異なる製品 (10)
-
Anti-MMP9 antibody [EP1254]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-MMP9 antibody [EP1254]
-
578 PE
PE Anti-MMP9 antibody [EP1254]
-
660 APC
APC Anti-MMP9 antibody [EP1254]
-
HRP Anti-MMP9 antibody [EP1254]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-MMP9 antibody [EP1254]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MMP9 antibody [EP1254]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-MMP9 antibody [EP1254]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-MMP9 antibody [EP1254]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-MMP9 antibody [EP1254]
Reactivity data
製品の詳細
ab204850 is the carrier-free version of ab76003.
Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Matrix metalloproteinase-9 profoundly influences tissue remodeling inflammation and angiogenesis. It does not form part of a larger protein complex but interacts closely with substrates in the extracellular matrix. MMP-9 plays important roles in processes such as embryogenesis reproduction and wound healing through the remodeling of surrounding tissues. The MMP-9 protein is often measured using assays like ELISA or analyzed via techniques such as Western blotting to determine its expression levels and activity in different biological contexts.
Pathways
MMP-9 participates in the matrix metalloproteinase pathway and the NF-kB signaling pathway. These pathways are essential in orchestrating processes such as tissue remodeling and inflammatory responses. MMP-9 acts alongside other matrix metalloproteinases including MMP-2 and is regulated by factors like cytokines growth factors and hormones ensuring the precision of extracellular matrix degradation during physiological processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell 40:1521-1536.e7 PubMed36400020
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 41:39-48 PubMed36328752
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 12:727915 PubMed34526970
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature cancer 2:545-562 PubMed35122017
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com